Description
EMERGENCY PURCHASE OF PACLITAXEL 150&300
First action · last action
2011-09-23 · 2011-09-23
Transactions
1
First transaction's obligation
$9,234
Base + all options value (sum of deltas)
$9,234
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
NAICS
423450 · MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-09-23+$9,234= $9,234
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-09-23 | +$9,234 | $9,234 | EMERGENCY PURCHASE OF PACLITAXEL 150&300 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI TKFSA4C7FJ52)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| V626U11166 | 626S-MURFREESBORO SMALL PURCHASE · 6505 · DRUGS AND BIOLOGICALS | $3,639 | FY2011 |
| V626U10468 | 626S-MURFREESBORO SMALL PURCHASE · 6505 · DRUGS AND BIOLOGICALS | $3,420 | FY2011 |
| VA652P11370 | 246-NETWORK CONTRACTING OFFICE 6 · 6505 · DRUGS AND BIOLOGICALS | $1,221 | FY2011 |
| VA5581P0067 | 246-NETWORK CONTRACTING OFFICE 6 · 6505 · DRUGS AND BIOLOGICALS | $3,095 | FY2011 |
| V554P08109 | 554S-DENVER SMALL PURCHASE · 6505 · DRUGS AND BIOLOGICALS | $5,500 | FY2010 |
| V554P08008 | 554S-DENVER SMALL PURCHASE · 6505 · DRUGS AND BIOLOGICALS | $10,440 | FY2010 |
Other recipients under 6505 from 549-DALLAS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25716P0113 | MCKESSON CORPORATION | 549-DALLAS | $11,630 | FY2016 |
| VA25716P0178 | MICROGENICS CORPORATION | 549-DALLAS | $109,260 | FY2016 |
| VA25715J2597 | GRIFOLS BIOLOGICALS LLC | 549-DALLAS | $129,005 | FY2015 |
| VA25715C0028 | BARD PERIPHERAL VASCULAR, INC. | 549-DALLAS | $11,400 | FY2015 |
| VA25714J3693 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 549-DALLAS | $7,512 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA549A11392_3600_-NONE-_-NONE- · retrieved 2026-09-26.